TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ANAB

AnaptysBio Inc

Healthcare · Biotechnology

54.90$ -0.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANAB
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
97.4% 95.0% 93.6% 76.7% 85.3% 86.8% 95.2% 86.1% 73.3% 89.9% 89.3% 96.1%
88.5% 91.8% 82.4% 24.7% 22.3% 39.3% 60.1% 77.1% 11.7% 8.0% 25.4% 65.4%
88.5% 91.8% 82.4% 75.4% 83.9% 86.0% 94.5% 85.2% 72.3% 86.4% 79.6% 85.5%
5.8% 2.2% 8.6% 0.5% 0.0% 0.0% 0.1% 0.2% 1.5% 8.4% 9.3%
0.0% 0.0% 0.0% 0.0% 0.0%
2.3% 1.0% 0.8% 0.2% 0.3% 0.7% 0.4% 0.4% 0.3%
0.0%
0.0%
76.1% 24.8% 36.8% 6.6% 4.4% 6.9% 4.8% 44.6% 57.1% 80.5% 85.4% 89.8%
46.6% 13.1% 9.2% 4.3% 4.3% 6.8% 4.8% 2.5% 4.3% 8.3% 9.4% 10.6%
0.5% 0.0% 0.0% 2.1% 1.5% 0.5% 0.1% 0.2% 0.3% 0.4% 0.4% 0.6%
1.7% 2.7% 3.7% 0.7% 1.1% 3.7% 1.0% 0.3% 0.5% 1.0% 0.8% 1.1%
19.1% 8.7% 22.2% 2.3% 0.1%
23.9% 75.2% 63.2% 93.4% 95.6% 93.1% 95.2% 55.4% 42.9% 19.5% 14.6% 10.2%
-180.6% -90.0% -88.3% -25.8% -28.8% -56.1% -63.4% -50.0% -73.8% -135.7% -156.9% -212.0%
9.9% 4.5% 4.2% 6.0% 4.8% 6.2% 6.6% 4.3% 4.6% 6.0% 5.9% 8.6%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?